Next Article in Journal
Impact of COVID-19 Mitigation Policy in South Korea on the Reduction of Preterm or Low Birth Weight Birth Rate: A Single Center Experience
Previous Article in Journal
Breastfeeding and Allergic Diseases: What’s New?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Novel Physique Index for the Screening of Skeletal Dysplasia at Birth

1
Department of Pediatrics and Child Health, Nihon University School of Medicine, Oyaguchi-kamimachi, Itabashi-ku, Tokyo 173-8610, Japan
2
Department of Neonatology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo 170-8476, Japan
*
Author to whom correspondence should be addressed.
Children 2021, 8(5), 331; https://doi.org/10.3390/children8050331
Submission received: 24 March 2021 / Revised: 18 April 2021 / Accepted: 23 April 2021 / Published: 25 April 2021

Abstract

:
This study aimed to devise a novel physique index and investigate its accuracy in identifying newborns with skeletal dysplasia in comparison with head circumference (HC)/height (HT) ratio. The birth weight (W), HT, and HC at birth of 1500 newborns were retrospectively collected. The linear regression equations and coefficients of determination (R2) were determined. The formulated equation was corrected by the mean weight for gestational age at birth (Wcorr) as a novel physique index for screening skeletal dysplasia. The index accuracy was assessed using receiver operating characteristic (ROC) curves in 11 newborns by fetal ultrasound and compared with that of the HC/HT ratio. The R2 values between W and HT, (HT)2, and (HT) 3 were 0.978, 0.990, and 0.993, respectively. Those between W and HC, (HC)2, and (HC)3 were 0.974, 0.984, and 0.988, respectively. W/Wcorr × (HC/HT)3 was used as a novel physique index. Seven newborns had skeletal dysplasia. Our novel physique index had a higher area under the curve (AUC), sensitivity, and specificity than the HC/HT ratio (AUC: 1.00 vs. 0.86, sensitivity: 1.00 vs. 0.86, and specificity: 1.00 vs. 0.75, respectively). Our novel physique index was more accurate than HC/HT ratio and has the potential to accurately identify newborns with skeletal dysplasia.

1. Introduction

Skeletal dysplasia is a disorder of the development and growth of bones or cartilages [1]. The most recent classification of skeletal dysplasia includes 42 groups and 436 diseases [1]. Skeletal dysplasia may lead to several complications during infancy. For example, patients with achondroplasia often develop otitis media, obstructive apneic attack, hydrocephalus, or stenosis of the craniocervical spine junction, necessitating surgical interventions [2]. In particular, stenosis of the craniocervical spine junction may cause sudden death in infancy. Therefore, early diagnosis of skeletal dysplasia is important to prevent or treat these complications [3,4].
Skeletal dysplasia is accurately diagnosed by radiographic and genetic findings [1,5]. Before radiographic and genetic examinations, the newborn has to be suspected of having skeletal dysplasia by the attending clinicians. Some cases can be suspected by the disproportionate short limbs at birth. However, approximately 20% of achondroplasia cases are not diagnosed by visual inspection during infancy but diagnosed during early childhood [3]; because hypochondroplasia has fewer clinical characteristics in infancy than achondroplasia, it is often diagnosed by the presence of a short stature at the age of 2−3 years [6].
Objective and easy-to-use screening methods are needed for pediatricians or neonatologists. For screening of fetal skeletal dysplasia, a section of the femoral length (FL) is generally used during fetal ultrasound examination [7,8]. However, the accuracy of this method is limited. Todros et al. had reported that only 11 (13%) out of 86 cases could be diagnosed with skeletal dysplasia using an FL of <−2.0 standard deviation scores (SDSs) in the second trimester [7]. Likewise, Kruts et al. have reported that only 11 (46%) out of 28 fetuses with skeletal dysplasia had an FL of <−2.0 SDS [8]. Even when the FL cut-off value was set to <−4.0 SDS, the sensitivity was 83% (10 out of 12 fetuses) [8].
Because many patients with skeletal dysplasia have short stature and head circumference (HC) expansion, the HC/height (HT) ratio is used to screen for skeletal dysplasia only in children, but not in newborns [9,10]. In pediatric achondroplasia and hypochondroplasia, the HC/HT ratio is more prominent compared to HT or HC alone [10]. However, the HC/HT ratio is used for screening for macrocephaly or abnormal body proportions, and not skeletal dysplasia [9,10]. To date, no studies have evaluated the HC/HT ratio at birth as a screening tool for skeletal dysplasia in newborns. Furthermore, because there is no accurate screening method for skeletal dysplasia at birth, we aimed to devise a new physique index as an objective and easy-to-use screening for skeletal dysplasia at birth.

2. Materials and Methods

2.1. Study Design

Two studies were performed. In Study 1, a novel physique index for screening skeletal dysplasia was developed, and in Study 2, the index was validated. In Study 1, a cohort of 1500 newborns born in 2016 at Nihon University Itabashi Hospital and Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, was included. In Study 2, a single hospital-based retrospective study using the data of 11,146 newborns born between 2006 and 2016 at the Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan was performed.

2.2. Definitions

Shortening of limbs was defined as a fetal FL of <−3.0 SDS for gestational age just prior to birth using fetal ultrasound by registered and practicing obstetricians [7,8,11].
Skeletal dysplasia was diagnosed using bone X-rays by the consensus of two registered and practicing radiologists specialized in skeletal dysplasia. In cases 1 to 6, the separate bone X-rays for upper limbs, lower limbs, head, chest, vertebral body, and pelvis were taken. In case 7, the bone X-ray of the whole body was taken on a single view.
Genetic tests for skeletal dysplasia were performed only for patients whose parents/guardians consented to perform such analyses. The genetic analyses were kindly performed using polymerase chain reaction, direct sequence, and multiplex ligation-dependent probe amplification by the genetic specialists in their laboratories as previously described (see Acknowledgments) [12,13,14], and the mutations were confirmed.
Small for gestational age (SGA) was defined using the following criteria based on sex-specific Japanese standards [15]: (i) birth weight (W) and HT of <10th percentile and (ii) W and/or HT of <−2.0 SDS for gestational age at birth [16]. The SDSs for W, HT, and HC at birth were calculated using nordiFIT (Novo Nordisk Pharma, Tokyo, Japan).

2.3. Study Methods and Statistical Analyses

Study 1: The following data were retrospectively collected: W, HT, HC, sex, and gestational age at birth. The W was measured using an electric scale, and HT was measured by the crown-to-heel length using a measuring tape or ruler by midwives or trained nurses. The coefficients of determination (R2) were determined between W and HT, (HT)2, and (HT)3 and between W and HC, (HC)2, and (HC)3 using linear regression analyses. Using the parameters for HT and HC with the highest R2, the equation was formulated and then corrected by the mean weight for gestational age at birth (Wcorr).
Study 2: Our physique index was validated using receiver operating characteristic (ROC) curves. The area under the curve (AUC), sensitivity, and specificity were compared with those of the HC/HT ratio in newborns who were suspected of having shortened limbs by fetal ultrasound examination. The cut-off value was determined using the maximum Youden index of the ROC curve. The Youden index is the point farthest from the boundary delineating the area under the curve (0.500 on the ROC curve) and represents the value of sensitivity + specificity – 1 [17]. All statistical analyses were performed using JMP version 14 (SAS Institute Inc., Tokyo, Japan) and Bellcurve for Excel version 3.20.

3. Results

3.1. Study 1

Of the 1500 newborns (744 (50%) boys and 756 (50%) girls), 832 (55%) and 668 (45%) were born to primiparous and multiparous mothers. In the modes of delivery, vaginal was 1097 (73%) and cesarean section was 403 (27%). The median gestational age at birth was 39 weeks (range, 22–41 weeks), the median W was 2935 g (range, 447–4935 g), the median HT was 47.8 cm (range, 27.4–57.2 cm), the median HC was 33.1 cm (range, 19.5–37.5 cm), and the median HC/HT ratio was 0.69 (range, 0.60–0.82).
The R2 values between W and HT, (HT)2, and (HT)3 were 0.978, 0.990, and 0.993, respectively. The R2 values between W and HC, (HC)2, and (HC)3 were 0.974, 0.984, and 0.988, respectively. Because both (HT)3 and (HC)3 had the highest R2 values and had a positive correlation with W (Figure 1), (HC/HT)3 was determined as the best formula, and W was multiplied by (HC/HT)3. Because the value of W × (HC/HT)3 was dependent on the gestational age, it was divided by Wcorr. The value of W/Wcorr × (HC/HT)3 was almost the same for all gestational ages (Figure 2). Finally, W/Wcorr × (HC/HT)3 was selected as the novel physique index.

3.2. Study 2

The number of newborns born during the study period was 11,146, of whom 11 (0.11%) had a fetal FL of <−3.0 SDS for gestational age. The detailed data of 11 newborns with a fetal FL of <−3.0 SDS for gestational age are shown in Table 1. Of the 11 newborns with a shortened FL, 7 (64%) had skeletal dysplasia. The final diagnosis of skeletal dysplasia was hypochondroplasia (n = 2), spondyloepiphyseal dysplasia congenita (n = 2), achondroplasia (n = 1), atelosteogenesis type III (n = 1), and thanatophoric dysplasia (n = 1). All infants with nonskeletal dysplasia were SGA (Table 1).
The AUC of the novel physique index was higher than that of the HC/HT ratio (1.00 and 0.86, respectively). When using the cut-off value of 0.795 for the HC/HT ratio or 0.450 for the novel physique index, the sensitivity and specificity were 0.86 and 0.75 in the HC/HT ratio or 1.00 and 1.00 in the novel physique index, respectively (Figure 3).

4. Discussion

This study demonstrated two novel findings. The HC/HT ratio at birth was limited in screening for skeletal dysplasia. The novel physique index (W/Wcorr × (HC/HT)3), having a higher accuracy as compared to the HC/HT ratio, was developed for screening of skeletal dysplasia at birth.
To date, the HC/HT ratio is the only available index for the screening of skeletal dysplasia in children aged 0−5 years [10]. For the first time, the present study showed a median HC/HT ratio of 0.69 in 1500 Japanese newborn infants, which was similar to a median HC/HT ratio of 0.70 in 3571 Argentinian children aged 0−5 years [10]. Thus, the same HC/HT ratio may be used regardless of age (≤5 years) and ethnicity. The present study also clarified the accuracy of the HC/HT ratio for the screening of skeletal dysplasia in newborns with a fetal FL of <−3.0 SDS. This ratio was found to produce false-positive and false-negative results, even though the number of patients was limited. Therefore, a more accurate index is required.
Flechtner et al. reported that some cases of skeletal dysplasia were included in SGA children [18]. Of the 93 SGA children, 16 (17%) were diagnosed with skeletal dysplasia and 17 (18%) had minor skeletal abnormalities. They also reported that 6 of 17 children with achondroplasia were SGA [18], indicating that the differentiation between SGA and skeletal dysplasia is very important. Further, it is difficult to screen for skeletal dysplasia based only on body weight and HT; therefore, we devised a novel physique index using the W and HC/HT ratios.
For the assessment of physique in children depending on the age, the body mass index and the Kaup index use body weight divided by height squared, while the Laurel index uses body weight divided by height cubed [19]. In newborns, the body weight is generally proportional to the height cubed [20], which is consistent with our present results (Figure 1). In addition, we also found that the HC cubed and W had the best correlations (Figure 1). In adults, the actual body weight divided by the ideal weight is used to assess obesity and leanness [21]. Similarly, W should be corrected by the mean (ideal) W based on the gestational age at birth, as used in the definition of SGA [15,22]. Hence, correction by the Wcorr produced the physique index. Its value was almost constant in all newborns, regardless of the gestational age at birth (Figure 2).
In an observational study using an FL cut-off of <−2.0 SDS for gestational age, the false-positive rate for detecting skeletal dysplasia was 87% [7]. In a study comparing 16 fetuses with an FL between −2.0 SDS and −4.0 SDS and 12 fetuses with an FL of <−4.0 SDS, the false-positive rates for skeletal dysplasia were 100% and 17%, respectively [8]. Because false-positive results are more frequent when using an FL of <−2.0 SDS, a Japanese obstetric guideline mentioned that an FL of −3.0 to −4.0 SDS should raise the suspicion of skeletal dysplasia [23]. Hence, in this study, limb shortening was defined as a fetal FL of <−3.0 SDS for gestational age. Of the 11 newborns with an FL of <−3.0 SDS, 7 had skeletal dysplasia as we expected. Our novel physique index detected all newborns with skeletal dysplasia (false-positive rate: 0%). Two cases of hypochondroplasia were included, suggesting that it can detect skeletal dysplasia in newborns without clinical characteristics in the neonatal period [6].
There were some limitations to our study. The sample size of the validation study was smaller because of the rarity of cases with skeletal dysplasia and severe SGA with an FL of <−3.0 SDS for gestational age. Moreover, this was an observational study performed in a single Japanese hospital. The utility of the index could not be examined in all diseases under skeletal dysplasia. Further multicenter studies including a large cohort of skeletal dysplasia should be conducted.

5. Conclusions

In conclusion, the novel physique index developed in this study was found to be more accurate compared to the HC/HT ratio and has the potential to accurately identify newborns with skeletal dysplasia. Further validation studies using a large cohort of newborns with skeletal dysplasia are required to evaluate the utility of this index.

Author Contributions

Conceptualization, R.A., K.M. and I.M.; methodology, R.A., N.N., K.M. and I.M.; validation, R.A. and I.M.; formal analysis, R.A., N.N. and I.M.; investigation, R.A., N.N., A.O., S.O., Y.F., I.T., K.M. and I.M.; resources, I.M.; writing—original draft preparation, R.A. and I.M.; writing—review and editing, N.N., A.O., S.O., Y.F., I.T. and K.M.; visualization, R.A. and I.M.; supervision, I.T.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was approved by the Ethics Committee of Nihon University School of Medicine (no. RK-190312-12) and Tokyo Metropolitan Ohtsuka Hospital (no. 2019-22). This study project is open to the public in Japanese at our website. The study was conducted in accordance with the Declaration of Helsinki.

Informed Consent Statement

The requirement of formal informed consent was waived because of the retrospective study design and anonymized data generated from regular practice.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We thank Masaki Takagi (Kojiya Child Clinic, Tokyo, Japan), Stephen Robertson (Dunedin School of Medicine, University of Otago, Dunedin, New Zealand), and Rika Kosaki (National Center for Child Health and Development, Tokyo, Japan), who performed the genetic analyses for the patients. We also thank Gen Nishimura (Saitama Medical University Hospital, Saitama, Japan) and Osamu Miyazaki (National Center for Child Health and Development, Tokyo, Japan) for their support in the patients’ diagnosis by radiological findings.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tiller, G.E.; Bellus, G.A. Skeletal dysplasia and heritable connective tissue disorders. In Avery’s Diseases of the Newborn, 10th ed.; Gleason, C.A., Juul, S., Eds.; Elsevier: Philadelphia, PA, USA, 2018; pp. 1450–1467. [Google Scholar]
  2. Unger, S.; Bonafé, L.; Gouze, E. Current Care and Investigational Therapies in Achondroplasia. Curr. Osteoporos. Rep. 2017, 15, 53–60. [Google Scholar] [CrossRef] [Green Version]
  3. Pereira, E. Achondroplasia. Pediatr. Rev. 2019, 40, 316–318. [Google Scholar] [CrossRef] [PubMed]
  4. Pauli, R.M. Achondroplasia: A comprehensive clinical review. Orphanet J. Rare Dis. 2019, 14, 1–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Krakow, D. Skeletal Dysplasias. Clin. Perinatol. 2015, 42, 301–319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Saito, T.; Nagasaki, K.; Nishimura, G.; Wada, M.; Nyuzuki, H.; Takagi, M.; Hasegawa, T.; Amano, N.; Murotsuki, J.; Sawai, H.; et al. Criteria for radiologic diagnosis of hypo-chondroplasia in neonates. Pediatr. Radiol. 2016, 46, 513–518. [Google Scholar] [CrossRef] [PubMed]
  7. Todros, T.; Massarenti, I.; Gaglioti, P.; Biolcati, M.; Botta, G.; Felice, C. Fetal short femur length in the second trimester and the outcome of pregnancy. BJOG Int. J. Obstet. Gynaecol. 2004, 111, 83–85. [Google Scholar] [CrossRef]
  8. Kurtz, A.B.; Needleman, L.; Wapner, R.J.; Hilpert, P.; Kuhlman, K.; Burns, P.N.; I Feld, R.; Mitchell, D.G.; Segal, S.; Blum, L. Usefulness of a short femur in the in utero detection of skeletal dysplasias. Radiol. 1990, 177, 197–200. [Google Scholar] [CrossRef]
  9. Del Pino, M.; Orden, A.B.; Arenas, M.A.; Fano, V. Argentine references for the assessment of body proportions from birth to 17 years of age. Arch. Argent. Pediatr. 2017, 115, 234–240. [Google Scholar] [CrossRef]
  10. Saunders, C.L.; Lejarraga, H.; Del Pino, M. Assessment of head size adjusted for height: An anthropometric tool for clinical use based on Argentinian data. Ann. Hum. Biol. 2006, 33, 415–423. [Google Scholar] [CrossRef]
  11. Goncalves, L.; Jeanty, P. Fetal biometry of skeletal dysplasias: A multicentric study. J. Ultrasound Med. 1994, 13, 977–985. [Google Scholar] [CrossRef] [PubMed]
  12. Takagi, M.; Kaneko-Schmitt, S.; Suzumori, N.; Nishimura, G.; Hasegawa, T. Atypical achondroplasia due to somatic mosaicism for the common thanatophoric dysplasia mutation R248C. Am. J. Med Genet. Part A 2011, 158A, 247–250. [Google Scholar] [CrossRef]
  13. Kusano, C.; Takagi, M.; Hori, N.; Murotsuki, J.; Nishimura, G.; Hasegawa, T. A novel mutation in the C-propeptide of COL2A1 causes atypical spondyloepiphyseal dysplasia congenita. Hum. Genome Var. 2017, 4, 17003. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Farrington-Rock, C.; Firestein, M.H.; Bicknell, L.S.; Superti-Furga, A.; Bacino, C.A.; Cormier-Daire, V.; Le Merrer, M.; Baumann, C.; Roume, J.; Rump, P.; et al. Mutations in two regions of FLNB result in atelosteogenesis I and III. Hum. Mutat. 2006, 27, 705–710. [Google Scholar] [CrossRef]
  15. Itabashi, K.; Miura, F.; Uehara, R.; Nakamura, Y. New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr. Int. 2014, 56, 702–708. [Google Scholar] [CrossRef] [PubMed]
  16. Fujita, K.; Nagasaka, M.; Iwatani, S.; Koda, T.; Kurokawa, D.; Yamana, K.; Nishida, K.; Taniguchi-Ikeda, M.; Uchino, E.; Shirai, C.; et al. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study. Pediatr. Int. 2015, 58, 372–376. [Google Scholar] [CrossRef]
  17. Fluss, R.; Faraggi, D.; Reiser, B. Estimation of the Youden Index and its Associated Cutoff Point. Biom. J. 2005, 47, 458–472. [Google Scholar] [CrossRef] [Green Version]
  18. Flechtner, I.; Lambot-Juhan, K.; Teissier, R.; Colmenares, A.; Baujat, G.; Beltrand, J.; Ajaltouni, Z.; Pauwels, C.; Pinto, G.; Samara-Boustani, D.; et al. Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients. Eur. J. Endocrinol. 2014, 170, 677–684. [Google Scholar] [CrossRef] [Green Version]
  19. Hattori, K.; Hirohara, T. Age change of power in weight/height(p) indices used as indicators of adiposity in Japanese. Am. J. Hum. Biol. 2002, 14, 275–279. [Google Scholar] [CrossRef] [PubMed]
  20. Lehingue, Y.; Remontet, L.; Munoz, F.; Mamelle, N. Birth ponderal index and body mass index reference curves in a large population. Am. J. Hum. Biol. 1998, 10, 327–340. [Google Scholar] [CrossRef]
  21. Tzamaloukas, A.H.; Murata, G.H.; E Hill, J.; Leger, A.; Macdonald, L.; Baron, S.; Hoffman, R.M. Disagreement between height/weight classifications of underweight, normal weight, and obesity in peritoneal dialysis patients. Adv. Perit. Dial. Conf. Perit. Dial. 2001, 17, 75–79. [Google Scholar]
  22. Nagasaka, M.; Morioka, I.; Yokota, T.; Fujita, K.; Kurokawa, D.; Koda, T.; Shibata, A.; Yamada, H.; Ito, Y.; Uchino, E.; et al. Incidence of short stature at 3 years of age in late preterm infants: A population-based study. Arch. Dis. Child. 2014, 100, 250–254. [Google Scholar] [CrossRef] [PubMed]
  23. Japan Society of Obstetrics and Gynecology. A guideline for the clinical practice for obstetrics and gynecology. Obstetrics 2017, 2017, 105–109. [Google Scholar]
Figure 1. Linear regression analyses between birth weight and height, (height)2, or (height)3 and between birth weight and head circumference, (head circumference)2, or (head circumference)3 at birth. R2, coefficients of determination; HC, head circumference; HT, height; W, birth weight.
Figure 1. Linear regression analyses between birth weight and height, (height)2, or (height)3 and between birth weight and head circumference, (head circumference)2, or (head circumference)3 at birth. R2, coefficients of determination; HC, head circumference; HT, height; W, birth weight.
Children 08 00331 g001
Figure 2. Physique index corrected by birth weight or birth weight corrected by mean weight for gestational age at birth. GA: gestational age at birth; HC: head circumference; HT: height; W: birth weight; Wcorr: mean weight for gestational age at birth.
Figure 2. Physique index corrected by birth weight or birth weight corrected by mean weight for gestational age at birth. GA: gestational age at birth; HC: head circumference; HT: height; W: birth weight; Wcorr: mean weight for gestational age at birth.
Children 08 00331 g002
Figure 3. Comparison of the results of the receiver operating characteristic curve analysis between head circumference/height ratio and the novel physique index in cases with shortening of limbs in utero. AUC, area under the curve; HC, head circumference; HT, height; W, birth weight; Wcorr, mean weight for gestational age at birth.
Figure 3. Comparison of the results of the receiver operating characteristic curve analysis between head circumference/height ratio and the novel physique index in cases with shortening of limbs in utero. AUC, area under the curve; HC, head circumference; HT, height; W, birth weight; Wcorr, mean weight for gestational age at birth.
Children 08 00331 g003
Table 1. Detailed data of 11 newborns with a fetal femoral length of <−3.0 standard deviation score for the gestational age.
Table 1. Detailed data of 11 newborns with a fetal femoral length of <−3.0 standard deviation score for the gestational age.
A. Physique
CaseSDS of Fetal FL
(GA at Measurement)
GA
at Birth
W (g)HT (cm)HC (cm)HC/HTW/Wcorr × (HC/HT)3
1−4.3 (36 weeks)39 weeks 0 days308846.035.00.760.45
2−3.9 (30 weeks)33 weeks 1 day200041.333.20.800.53
3−4.4 (36 weeks)37 weeks 6 days306845.536.20.800.57
4−6.0 (38 weeks)39 weeks 2 days298841.335.50.860.63
5−6.8 (36 weeks)37 weeks 0 days257040.537.20.920.75
6−7.8 (37 weeks)38 weeks 2 days261237.034.20.920.72
7−11.4 (36 weeks)36 weeks 4 days176231.032.71.100.80
8−3.2 (27 weeks)27 weeks 2 days68032.125.40.790.32
9−5.1 (30 weeks)30 weeks 6 days68432.2260.810.23
10−3.4 (39 weeks)39 weeks 5 days201044.230.50.690.21
11−3.4 (35 weeks)36 weeks 2 days201443.131.50.730.31
B. Radiological and Genetic Findings
CaseRadiological FindingsGenetic FindingsFinal Diagnosis
1Large calvarium, dorsal scalloping of vertebral bodies, horizontal acetabular margins, narrow sciatic notch, short tubular bones, oval radiolucent area in the proximal femur, cone-shaped middle phalanges, and trident handFGFR3
c.1138 G>A
p.Gly380Arg
Achondroplasia
2Protuberance of frontal bones, small skull base, horizontal acetabular margins, narrow sciatic notch, mild short tubular bones, cone-shaped middle phalanges, and trident hand. No evidence of dorsal scalloping of vertebral bodies and metaphyseal flaring of the distal femurNEHypochondroplasia
3Protuberance of frontal bones, horizontal acetabular margins, narrow sciatic notch, mild short tubular bones, cone-shaped middle phalanges, and trident hand. No evidence of metaphyseal flaring of the distal femurFGFR3
c.1620C>A
p.Asn540Lys
Hypochondroplasia
4Lack of ossification of the os pubis, distal femur, and proximal tibial epiphyses. Pear-shaped vertebra, short iliac bones in craniocaudal dimension, and horizontal acetabular marginsCOL2A1
c.5404del
Spondyloepiphyseal
dysplasia congenita
5Lack of ossification of the os pubis, distal femur, and proximal tibial epiphyses. Pear-shaped vertebra and horizontal acetabular marginsCOL2A1
c.2094G>A
p.Gly699Asp
Spondyloepiphyseal
dysplasia congenita
6Small vertebral bodies and coronal clefts throughout the thoracic and lumbar spine, flared iliac wings, steep acetabula, and disproportionately short and distally tapered humerus and femurFLNB
c.650C>T
p.Pro217Leu
Atelosteogenesis
type III
7Narrow thorax due to a short rim; distinct flatness of the ossification centers of the vertebral bodies; horizontal inferior margins of the iliac bones; and very short, broad, and bowed long tubular bonesNEThanatophoric
dysplasia
8NormalNESGA
9NormalNESGA
10NormalNESGA
11NormalNESGA
FL, femoral length; GA, gestational age; HC, head circumference; HT, height; NE, not examined; SDS, standard deviation score; W, weight; Wcorr; weight corrected by the mean weight for the gestational age.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Aoki, R.; Nagano, N.; Okahashi, A.; Ohashi, S.; Fujinaka, Y.; Takigawa, I.; Masunaga, K.; Morioka, I. Novel Physique Index for the Screening of Skeletal Dysplasia at Birth. Children 2021, 8, 331. https://doi.org/10.3390/children8050331

AMA Style

Aoki R, Nagano N, Okahashi A, Ohashi S, Fujinaka Y, Takigawa I, Masunaga K, Morioka I. Novel Physique Index for the Screening of Skeletal Dysplasia at Birth. Children. 2021; 8(5):331. https://doi.org/10.3390/children8050331

Chicago/Turabian Style

Aoki, Ryoji, Nobuhiko Nagano, Aya Okahashi, Shoko Ohashi, Yoshinori Fujinaka, Itsuro Takigawa, Ken Masunaga, and Ichiro Morioka. 2021. "Novel Physique Index for the Screening of Skeletal Dysplasia at Birth" Children 8, no. 5: 331. https://doi.org/10.3390/children8050331

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop